Литература Aalkjaer C, Mulvany mj, Nyborg nc. Atrial natriuretic factor causes specific relaxation of rat renal arcuate arteries



Yüklə 192,52 Kb.
səhifə1/4
tarix24.12.2017
ölçüsü192,52 Kb.
#17776
növüЛитература
  1   2   3   4

Литература

  1. Aalkjaer C, Mulvany MJ, Nyborg NC. Atrial natriuretic factor causes specific relaxation of rat renal arcuate arteries. Br J Pharmacol. 1985;86(2) 447-453.

  2. Abdelalim EM, Takada T, Torii R, Tooyama I. Molecular cloning of BNP from heart and its immunohistochemical localization in the hypothalamus of monkey. Peptides. 2006;27(7):1886-1893. doi: 10.1016/j.peptides.2006.01.001

  3. Abdelalim EM, Masuda C, Bellier JP, Saito A, Yamamoto S, Mori N, Tooyama I. Distribution of natriuretic peptide receptor-C immunoreactivity in the rat brainstem and its relationship to cholinergic and catecholaminergic neurons. Neuroscience. 2008;155(1):192-202. doi: 10.1016/j.neuroscience.2008.05.020

  4. Aburaya M, Suzuki E, Minamino N, Kangawa K, Tanaka K, Matsuo H. Concentration and molecular forms of brain natriuretic peptide in rat plasma and spinal cord. Biochem Biophys Res Commun. 1991;177(1):40-47.

  5. Ackermann U, Khanna J, Irizawa TG. Atrial natriuretic factor alters autonomic interactions in the control of heart rate in conscious rats. Can J Physiol Pharmacol. 1988;66(7):930-936.

  6. Alexander MR, Knowles JW, Nishikimi T, Maeda N. Increased atherosclerosis and smooth muscle cell hypertrophy in natriuretic peptide receptor A–/–apolipoprotein E–/– mice. Arterioscler Thromb Vasc Biol. 2003;23(6):1077-1082. doi: 10.1161/01.ATV.0000071702.45741.2E

  7. Allen DE, Gellai M. Cardioinhibitory effect of atrial peptide in conscious rats. Am J Physiol. 1987;252(3 Pt 2):R610-R616.

  8. Allen MJ, Gilmour SM, Singer M, Bennett ED. Effects of atrial natriuretic peptide on systemic haemodynamics and cardiac function in normal man. Cardiovasc Res. 1989;23(1):70-75.

  9. Almeida FA, Suzuki M, Maack T. Atrial natriuretic factor increases hematocrit and decreases plasma volume in nephrectomized rats. Life Sci. 1986;39(13):1193-1199.

  10. Al-Obaidi M, Whitaker EM, Karim F. The effect of discrete stimulation of carotid body chemoreceptors on atrial natriuretic peptide in anaesthetized dogs. J Physiol. 1991;443:519-531.

  11. Ando S, Imaizumi T, Harada S, Hirooka Y, Takeshita A. Atrial natriuretic peptide increases human capillary filtration and venous distensibility. J Hypertens. 1992;10(5):451-457.

  12. Andrade FA, Restini CB, Grando MD, Ramalho LN, Bendhack LM.Vascular relaxation induced by C-type natriuretic peptide involves the ca2+/NO-synthase/NO pathway. PLoS One. 2014;9(5):e95446. doi:10.1371/journal.pone.0095446

  13. Anker SD, Ponikowski P, Mitrovic V, Peacock WF, Filippatos G. Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies. Eur Heart J. 2015;36(12):715-723. doi: 10.1093/eurheartj/ehu484

  14. Appel RG, Wang J, Simonson MS, Dunn MJ. A mechanism by which atrial natriuretic factor mediates its glomerular actions. Am J Physiol. 1986;251(6 Pt 2):F1036-F1042.

  15. Arjamaa O, Nikinmaa M. Hypoxia regulates the natriuretic peptide system. Int J Physiol Pathophysiol Pharmacol. 2011;3(3):191-201.

  16. Armaly Z, Assady S, Abassi Z. Corin: a new player in the regulation of salt-water balance and blood pressure. Curr Opin Nephrol Hypertens. 2013;22(6):713-722. doi: 10.1097/01.mnh.0000435609.35789.32

  17. Atarashi K, Mulrow PJ, Franco-Saenz R. Effect of atrial peptides on aldosterone production. J Clin Invest. 1985;76(5):1807-1811. doi: 10.1172/JCI112172

  18. Azer J, Hua R, Vella K, Rose RA. Natriuretic peptides regulate heart rate and sinoatrial node function by activating multiple natriuretic peptide receptors. J Mol Cell Cardiol. 2012;53(5):715-724. doi: 10.1016/j.yjmcc.2012.08.020

  19. Azer J, Hua R, Krishnaswamy PS, Rose RA. Effects of natriuretic peptides on electrical conduction in the sinoatrial node and atrial myocardium of the heart. J Physiol. 2014;592(Pt 5):1025-1045. doi: 10.1113/jphysiol.2013.265405

  20. Banks M, Wei CM, Kim CH, Burnett JC, Miller VM. Mechanism of relaxations to C-type natriuretic peptide in veins. Am J Physiol. 1996;271(5 Pt 2):H1907-H1911.

  21. Barasch E, Gottdiener JS, Aurigemma G, Kitzman DW, Han J, Kop WJ, Tracy RP. Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study. Circ Heart Fail. 2009;2(4):303-310. doi: 10.1161/CIRCHEARTFAILURE.108.828343

  22. Barmashenko G, Buttgereit J, Herring N, Bader M, Ozcelik C, Manahan-Vaughan D, Braunewell KH. Regulation of hippocampal synaptic plasticity thresholds and changes in exploratory and learning behavior in dominant negative NPR-B mutant rats. Front Mol Neurosci. 2014;7:95.eCollection.

  23. Bauer WR, Neubauer S, Obitz G, Ertl G. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart. J Mol Cell Cardiol 1994;26(4):527-537. doi: 10.1006/jmcc.1994.1063

  24. Beaulieu P, Cardinal R, De Léan A, Lambert C. Direct chronotropic effects of atrial and C-type natriuretic peptides in anaesthetized dogs. Br J Pharmacol. 1996;118(7):1790-1796.

  25. Becker BF, Jacob M, Leipert S, Salmon AH, Chappell D. Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases. Br J Clin Pharmacol. 2015;80(3):389-402. doi: 10.1111/bcp.12629

  26. Bełtowski J, Wójcicka G. Regulation of renal tubular sodium transport by cardiac natriuretic peptides: two decades of research. Med Sci Monit. 2002;8(2):RA39-RA52.

  27. Bergey JL, Kotler D. Effects of atriopeptins I, II and III on atrial contractility, sinus nodal rate (guinea pig) and agonist-induced tension in rabbit aortic strips. Eur J Pharmacol. 1985;110(2):277-281.

  28. Bialik GM, Abassi ZA, Hammel I, Winaver J, Lewinson D. Evaluation of atrial natriuretic peptide and brain natriuretic peptide in atrial granules of rats with experimental congestive heart failure. J Histochem Cytochem. 2001;49(10):1293-1300.

  29. Birkenfeld AL, Boschmann M, Moro C, Adams F, Heusser K, Franke G, Berlan M, Luft FC, Lafontan M, Jordan J. Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. J Clin Endocrinol Metab. 2005;90(6):3622-3628. doi: 10.1210/jc.2004-1953

  30. Bohara M, Kambe Y, Nagayama T, Tokimura H, Arita K, Miyata A. C-type natriuretic peptide modulates permeability of the blood-brain barrier. J Cereb Blood Flow Metab. 2014;34(4):589-596. doi: 10.1038/jcbfm.2013.234

  31. Bolli P, Müller FB, Linder L, Raine AE, Resink TJ, Erne P, Kiowski W, Ritz R, Bühler FR. The vasodilator potency of atrial natriuretic peptide in man. Circulation. 1987;75(1):221-228.

  32. Bordicchia M, Liu D, Amri EZ, Ailhaud G, Dessì-Fulgheri P, Zhang C, Takahashi N, Sarzani R, Collins S. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J Clin Invest. 2012;122(3):1022-1036. doi: 10.1172/JCI59701

  33. Bouchie JL, Hansen H, Feener EP. Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen system. Arterioscler Thromb Vasc Biol. 1998;18(11):1771-1779.

  34. Bruegger D, Jacob M, Rehm M, Loetsch M, Welsch U, Conzen P, Becker BF. Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts. Am J Physiol Heart Circ Physiol. 2005;289(5):H1993-H1999. doi: 10.1152/ajpheart.00218.2005

  35. Brusq JM, Mayoux E, Guigui L, Kirilovsky J. Effects of C-type natriuretic peptide on rat cardiac contractility. Br J Pharmacol. 1999;128(1):206-212. doi: 10.1038/sj.bjp.0702766

  36. Bruun NE, Skøtt P, Giese J. Renal and endocrine effects of physiological variations of atrial natriuretic factor in normal humans. Am J Physiol. 1991;260(1 Pt 2):R217-R224.

  37. Burnett JC, Granger JP. Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol. 1984;247(5 Pt 2):F863-F686.

  38. Cabiati M, Sabatino L, Caruso R, Caselli C, Prescimone T, Giannessi D, Del Ry S. Gene expression of C-type natriuretic peptide and of its specific receptor NPR-B in human leukocytes of healthy and heart failure subjects. Peptides. 2012;37(2):240-246. doi: 10.1016/j.peptides.2012.07.026

  39. Calderone A, Bel-Hadj S, Drapeau J, El-Helou V, Gosselin H, Clement R, Villeneuve L. Scar myofibroblasts of the infarcted rat heart express natriuretic peptides. J Cell Physiol. 2006;207(1):165-713. doi: 10.1002/jcp.20548

  40. Cameron VA, Aitken GD, Ellmers LJ, Kennedy MA, Espiner EA. The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology. 1996;137(3):817-824. doi: 10.1210/endo.137.3.8603590

  41. Cargill RI, Struthers AD, Lipworth BJ. Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man. Clin Sci. (Lond). 1995;88(1):81-86.

  42. Cataliotti A, Giordano M, De Pascale E, Giordano G, Castellino P, Jougasaki M, Costello LC, Boerrigter G, Tsuruda T, Belluardo P, Lee SC, Huntley B. CNP production in the kidney and effects of protein intake restriction in nephrotic syndrome. Am J Physiol Renal Physiol. 2002;283(3):F464-F472. doi :10.1152/ajprenal.00372.2001

  43. Cha SA, Park BM, Gao S, Kim SH. Stimulation of ANP by angiotensin-(1—9) via the angiotensin type 2 receptor. Life Sci. 2013;93(24):934-940. doi: 10.1016/j.lfs.2013.10.020

  44. Chabrier PE, Roubert P, Braquet P. Specific binding of atrial natriuretic factor in brain microvessels. Proc Natl Acad Sci USA. 1987;84(7):2078-2081.

  45. Chabrier PE, Roubert P, Plas P, Braquet P. Blood-brain barrier and atrial natriuretic factor. Can J Physiol Pharmacol. 1988;66(3):276-279.

  46. Chappell D, Bruegger D, Potzel J, Jacob M, Brettner F, Vogeser M, Conzen P, Becker BF, Rehm M. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx. Crit Care. 2014;18(5):538. doi: 10.1186/s13054-014-0538-5

  47. Charles CJ, Richards AM, Espiner EA. Central C-type natriuretic peptide but not atrial natriuretic factor lowers blood pressure and adrenocortical secretion in normal conscious sheep. Endocrinology. 1992;131(4):1721-1726.

  48. Charles CJ, Espiner EA, Richards AM, Nicholls MG, Yandle TG. Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep. Am J Physiol. 1996;270(6 Pt 2):R1324-R1331.

  49. Chartier L, Schiffrin EL. Role of calcium in effects of atrial natriuretic peptide on aldosterone production in adrenal glomerulosa cells. Am J Physiol. 1987;252(4 Pt 1):E485-E491.

  50. Chauhan SD, Nilsson H, Ahluwalia A, Hobbs AJ. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc Natl Acad Sci USA. 2003;100(3):1426-1431. doi: 10.1073/pnas.0336365100

  51. Chen HH, Burnett JC. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol. 1998;32:Suppl. 3:S22-S28.

  52. Chen HH, Cataliotti A, Schirger JA, Martin FL, Burnett JC. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure. Am J Physiol Regul Integr Comp Physiol. 2005;288(5):R1093-R1097. doi: 10.1152/ajpregu.00682.2004

  53. Chen JJ, Zhang J, Cai Y, Zhou YB, Wen GB, Tang CS, Qi YF, Jiang ZS. C-type natriuretic peptide inhibiting vascular calcification might involve decreasing bone morphogenic protein 2 and osteopontin levels. Mol Cell Biochem. 2014;392(1-2):65-76. doi: 10.1007/s11010-14-2019-1

  54. Chen YF. Atrial natriuretic peptide in hypoxia. Peptides. 2005;26(6):1068-1077. doi: 10.1016/j.peptides.2004.08.030

  55. Chien YW, Frohlich ED, Trippodo NC. Atrial natriuretic peptide increases resistance to venous return in rats. Am J Physiol. 1987;252(5 Pt 2):H894-H899.

  56. Chien Y, Pegram BL, Kardon MB, Frohlich ED. ANF does not increase total body venous compliance in conscious rats with myocardial infarction. Am J Physiol. 1992;262(2 Pt 2):H432-H436.

  57. Chu A, Morris KG, Kuehl WD, Cusma J, Navetta F, Cobb FR. Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans. Circulation. 1989;80(6):1627-1635.

  58. Clerico A, Recchia FA, Passino C, Emdin M. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol. 2006;290(1):H17-H29. doi: 10.1152/ajpheart.00684.2005

  59. Cogan MG. Atrial natriuretic factor can increase renal solute excretion primarily by raising glomerular filtration. Am J Physiol. 1986;250(4 Pt 2):F710-F714.

  60. Crandall ME, Gregg CM. In vitro evidence for an inhibitory effect of atrial natriuretic peptide on vasopressin release. Neuroendocrinology. 1986;44(4):439-445.

  61. Curry FR, Rygh CB, Karlsen T, Wiig H, Adamson RH, Clark JF, Lin YC, Gassner B, Thorsen F, Moen I, Tenstad O, Kuhn M, Reed RK. Atrial natriuretic peptide modulation of albumin clearance and contrast agent permeability in mouse skeletal muscle and skin: role in regulation of plasma volume. J Physiol. 2010;588(Pt 2):325-339. doi :10.1113/jphysiol.2009.180463

  62. De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981;28(1):89-94.

  63. De Bold AJ, Flynn TG. Cardionatrin I - a novel heart peptide with potent diuretic and natriuretic properties. Life Sci. 1983;33(3):97-100.

  64. De Léan A, Racz K, Gutkowska J, Nguyen TT, Cantin M, Genest J. Specific receptor-mediated inhibition by synthetic atrial natriuretic factor of hormone-stimulated steroidogenesis in cultured bovine adrenal cells. Endocrinology. 1984;115(4):1636-163, 168. doi :10.1210/endo-115-4-1636

  65. De Wardener HE, Mills IH, Clapham WF. Studies on the efferent mechanism of the sodium diuresis which follows the administration of intravenous saline in the dog. Clin Sci 1961;21:249-625.

  66. Dean AD, Vehaskari VM, Greenwald JE. Synthesis and localization of C-type natriuretic peptide in mammalian kidney. Am J Physiol. 1994;266(3 Pt 2):F491-F496.

  67. Del Ry S, Passino C, Emdin M, Giannessi D. C-type natriuretic peptide and heart failure. Pharmacol Res. 2006;54(5):326-333. doi: 10.1016/j.phrs.2006.06.011

  68. Del Ry S, Cabiati M, Vozzi F, Battolla B, Caselli C, Forini F, Segnani C, Prescimone T, Giannessi D, Mattii L. Expression of C-type natriuretic peptide and its receptor NPR-B in cardiomyocytes. Peptides. 2011;32(8):1713-1718. doi: 10.1016/j.peptides.2011.06.014

  69. Deschatrettes E, Jouvert P, Zwiller J. Overexpression of cyclic GMP-dependent protein kinase reduces MeCP2 and HDAC2 expression. Brain Behav. 2012;2(6):732-740. doi: 10.1002/brb3.92

  70. DiCicco-Bloom E, Lelièvre V, Zhou X, Rodriguez W, Tam J, Waschek JA. Embryonic expression and multifunctional actions of the natriuretic peptides and receptors in the developing nervous system. Dev Biol. 2004;271(1):161-175. doi: 10.1016/j.ydbio.2004.03.028

  71. Dickey DM, Potter LR. Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation. J Mol Cell Cardiol. 2011;51(1):67-71. doi: 10.1016/j.yjmcc.2011.03.013

  72. Doorenbos CJ, Blauw GJ, van Brummelen P. Arterial and venous effects of atrial natriuretic peptide in the human forearm. Am J Hypertens. 1991;4(4 Pt 1):333-340.

  73. Doyle DD, Upshaw-Earley J, Bell EL, Palfrey HC. Natriuretic peptide receptor-B in adult rat ventricle is predominantly confined to the nonmyocyte population. Am J Physiol Heart Circ Physiol. 2002;282(6):H2117-H2123. doi: 10.1152/ajpheart.00988.2001

  74. Drexler H, Zeiher AM, Holtz J, Meinertz T, Just H. Effect of atrial natriuretic factor on coronary vascular tone. Z Kardiol. 1990;79(9):621-627.

  75. Dubois-Rande JL, Adnot S, Benvenuti C, Merlet P, Hittinger L, Sediame S, Chabrier E, Braquet P, Castaigne A. Hemodynamic response to intracoronary infusion of atrial natriuretic factor in patients with normal or altered left ventricular function. J Cardiovasc Pharmacol. 1991;17(4):608-614.

  76. Dunn BR, Ichikawa I, Pfeffer JM, Troy JL, Brenner BM. Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the anesthetized rat. Circ Res. 1986;59(3):237-246.

  77. Ebert TJ, Cowley AW. Atrial natriuretic factor attenuates carotid baroreflex-mediated cardioacceleration in humans. Am J Physiol. 1988;254(4 Pt 2):R590-R594.

  78. Egom EE, Vella K, Hua R, Jansen HJ, Moghtadaei M, Polina I, Bogachev O, Hurnik R, Mackasey M, Rafferty S, Ray G, Rose RA. Impaired sinoatrial node function and increased susceptibility to atrial fibrillation in mice lacking natriuretic peptide receptor C. J Physiol. 2015;593(5):1127-1146. doi: 10.1113/jphysiol.2014.283135

  79. Ehara S, Nakamura Y, Matsumoto K, Hasegawa T, Shimada K, Takagi M, Hanatani A, Izumi Y, Terashima M, Yoshiyama M. Effects of intravenous atrial natriuretic peptide and nitroglycerin on coronary vasodilation and flow velocity determined using 3 T magnetic resonance imaging in patients with nonischemic heart failure. Heart Vessels. 2013;28(5):596-605. doi: 10.1007/s00380-012-0292-z

  80. Eiskjaer H, Nielsen CB, Sørensen SS, Pedersen EB. Renal and hormonal actions of atrial natriuretic peptide during angiotensin II or noradrenaline infusion in man. Eur J Clin Invest. 1996;26(7):584-595.

  81. Engeli S, Birkenfeld AL, Badin PM, Bourlier V, Louche K, Viguerie N, Thalamas C, Montastier E, Larrouy D, Harant I, de Glisezinski I, Lieske S, Reinke J, Beckmann B, Langin D, Jordan J, Moro C. Natriuretic peptides enhance the oxidative capacity of human skeletal muscle. J Clin Invest. 2012;122(12):4675-4679. doi: 10.1172/JCI64526

  82. Erdos EG, Skidgel RA. Neutral endopeptidase 24.11. (enkephalinase) and related regulators of peptide hormones. FASEB J. 1989;3(2):145-151.

  83. Feiteiro J, Santos-Silva AJ, Verde I, Cairrão E. Testosterone and atrial natriuretic peptide share the same pathway to induce vasorelaxation of human umbilical artery. J Cardiovasc Pharmacol. 2014;63(5):461-465. doi: 10.1097/FJC.0000000000000060

  84. Ferrari AU, Daffonchio A, Cavallazzi A, Gerosa S, Napoletano G, Mancia G. Effect of atrial natriuretic factor on arterial baroreceptor control of heart rate and blood pressure in conscious rats. J Hypertens Suppl. 1988;6(4):S284-S286.

  85. Fink G, Dow RC, Casley D, Johnston CI, Lim AT, Copolov DL, Bennie J, Carroll S, Dick H. Atrial natriuretic peptide is a physiological inhibitor of ACTH release: evidence from immunoneutralization in vivo. J Endocrinol. 1991;131(3):R9-R12.

  86. Floras JS. Sympathoinhibitory effects of atrial natriuretic factor in normal humans. Circulation. 1990;81(6):1860-1873.

  87. Florkowski CM, Richards AM, Espiner EA, Yandle TG, Frampton C. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. Am J Physiol. 1994;266(4 Pt 2):R1244-R1250.

  88. Ford GA, Eichler HG, Hoffman BB, Blaschke TF. Venous responsiveness to atrial natriuretic factor in man. Br J Clin Pharmacol. 1988;26(6):797-799.

  89. Fried TA, McCoy RN, Osgood RW, Stein JH. Effect of atriopeptin II on determinants of glomerular filtration rate in the in vitro perfused dog glomerulus. Am J Physiol. 1986;250(6 Pt 2):F1119-F1122.

  90. Fujita S, Shimojo N, Terasaki F, Otsuka K, Hosotani N, Kohda Y, Tanaka T, Nishioka T, Yoshida T, Hiroe M, Kitaura Y, Ishizaka N, Imanaka-Yoshida K. Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1/endothelin receptor A cascade. Heart Vessels. 2013;28(5):646-657. doi: 10.1007/s00380-012-0311-0

  91. Fujita T, Ito Y, Noda H, Sato Y, Ando K, Kangawa K, Matsuo H. Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man. J Clin Invest. 1987;80(3):832-840. doi: 10.1172/JCI113141

  92. Furuya M, Yoshida M, Hayashi Y, Ohnuma N, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1991;177(3):927-931.

  93. Ganesh SK, Tragante V, Guo W, Guo Y, Lanktree MB, Smith EN, Johnson T, Castillo BA, Barnard J, Baumert J, Chang YP, Elbers CC, Farrall M, Fischer ME, Franceschini N, Gaunt TR, Gho JM, Gieger C, Gong Y, Isaacs A, et al. Loci influencing blood pressure identified using a cardiovascular gene-centric array. Hum Mol Genet. 2013;22(8):1663-1678.

  94. Ganong WF. Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin Exp Pharmacol Physiol. 2000;27(5-6):422-427.

  95. Gao S, Park BM, Cha SA, Park WH, Park BH, Kim SH. Angiotensin AT2 receptor agonist stimulates high stretch induced-ANP secretion via I3K/NO/sGC/PKG/pathway. Peptides. 2013;47:36-44. doi: 10.1016/j.peptides.2013.06.008

  96. Garcha RS, Hughes AD. CNP, but not ANP or BNP, relax human isolated subcutaneous resistance arteries by an action involving cyclic GMP and BKCa channels. J Renin Angiotensin Aldosterone Syst. 2006;7(2):87-91. doi: 10.3317/jraas.2006.014

  97. Gardner DG, Vlasuk GP, Baxter JD, Fiddes JC, Lewicki JA. Identification of atrial natriuretic factor gene transcripts in the central nervous system of the rat. Proc Natl Acad Sci USA. 1987;84(8):2175-2179.

  98. Glass H, Gutkowska J, Favaretto AL, Antunes-Rodrigues J. Correlations between ANP concentrations in atria, plasma and cerebral structures and sodium chloride preference in Wistar rats. Braz J Med Biol Res. 1997;30(1):65-68.

  99. Goodfriend TL, Elliott ME, Atlas SA. Actions of synthetic atrial natriuretic factor on bovine adrenal glomerulosa. Life Sci. 1984;35(16):1675-1682.

  100. Goy MF, Oliver PM, Purdy KE, Knowles JW, Fox JE, Mohler PJ, Qian X, Smithies O, Maeda N. Evidence for a novel natriuretic peptide receptor that prefers brain natriuretic peptide over atrial natriuretic peptide. Biochem J. 2001;358(Pt 2):379-387.

  101. Groban L, Cowley AW, Ebert TJ. Atrial natriuretic peptide augments forearm capillary filtration in humans. Am J Physiol. 1990;259(1 Pt 2):H258-H263.

  102. Guild SB, Cramb G. Characterisation of the effects of natriuretic peptides upon ACTH secretion from the mouse pituitary. Mol Cell Endocrinol. 1999;152(1-2):11-19.

  103. Guo LJ, Alli AA, Eaton DC, Bao HF. ENaC is regulated by natriuretic peptide receptor-dependent cGMP signaling. Am J Physiol Renal Physiol. 2013;304(7):F930-F937.

  104. Guo S, Goetze JP, Jeppesen JL, Burnett JC, Olesen J, Jansen-Olesen I, Ashina M. Effect of natriuretic peptides on cerebral artery blood flow in healthy volunteers.
    Yüklə 192,52 Kb.

    Dostları ilə paylaş:
  1   2   3   4



Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©www.genderi.org 2024
rəhbərliyinə müraciət
    Ana səhifə
Psixologiya